Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Families and children news

Show

From To
Tenofovir use during pregnancy doesn't affect infant size or weight at birth, but may by one year of age

Use of tenofovir during pregnancy does not have an adverse impact on infant weight or size at birth, according to a large US study published in the

Published
03 April 2012
By
Michael Carter
South Africa: HIV Infection Rate in Babies Drops in Gauteng

The HIV infection rate in newborn babies has decreased by more than half in Gauteng, says the provincial Department of Health and Social Development.

Published
02 April 2012
From
AllAfrica
Breastfeeding, Not Formula, for South Africa's HIV-Positive Mothers

South Africa's nine provinces will begin phasing out provision of free formula to HIV-positive mothers and implement a new policy on breast-feeding from Sunday. But despite the clarity of the policy and its supporting data, vocal critics, including respected individuals from leading medical and academic institutions, have decried the choice.

Published
01 April 2012
From
Inter Press Service
Diagnosing and preventing TB in children

In the second part of this series, HATIP looks at diagnosing and preventing TB in children.

Published
30 March 2012
From
HIV & AIDS treatment in practice
Kenya: Only 4% of pregnant women started ART within 6 months of diagnosis

Only 4% of HIV-positive pregnant women estimated as needing ART for their own health (CD4 cell counts under 350 cells/mm3) started ART within six months of getting an

Published
30 March 2012
By
Carole Leach-Lemens
FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1

Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved INTELENCE® (etravirine) to be administered in combination with other antiretroviral (ARV) medications for treatment of human immunodeficiency virus 1 (HIV-1) in treatment-experienced pediatric patients (6 years to less than 18 years old) who are experiencing virologic failure with HIV-1 strains resistant to a non-nucleoside reverse transcriptase inhibitor (NNRTI) and other ARVs.

Published
28 March 2012
From
Janssen press release
Over 20 million individuals infected with hepatitis E in Asia and Africa

New research funded by the World Health Organization estimates that 20.1 million individuals were infected with hepatitis E virus genotypes one and two across nine world regions in 2005. According to findings available in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, there were 3.4 million symptomatic cases, 70,000 deaths, and 3,000 stillbirths from HEV that year in countries throughout Asia and Africa.

Published
27 March 2012
From
Eurekalert Inf Dis
TB, HIV, mothers and children: time for action

This year’s World TB Day edition of HATIP focusses on the needs of pregnant women and children with TB.

Published
23 March 2012
From
HIV & AIDS treatment in practice
SOUTH AFRICA: Children with TB below the health radar

To a casual observer the two dozen children running round in the grassy schoolyard look like ordinary kids playing, but the surrounding buildings are the wards of the Brooklyn Chest Hospital (BCH), which specializes in treating severe cases of tuberculosis (TB), a disease rarely associated with children.

Published
23 March 2012
From
IRIN Plus News
Childhood tuberculosis a “hidden epidemic”

Globally, an estimated 200 children die from tuberculosis every day despite the availability of cheap drugs to prevent and treat this highly infectious condition, the UN World Health Organization (WHO) has said.

Published
22 March 2012
From
IRIN Plus News

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.